ArtiFascia Pivotal NEOART study has been initiated
- January 7, 2020
- 9:14 am
Nurami has announced the initiation of NEOART clinical study to test its Dural repair patch – ArtiFascia®. Multiple leading EU medical centers participate in the study. The enrollment of patients is ongoing.
https://clinicaltrials.gov/ct2/show/NCT04145544?term=artifascia&draw=2&rank=1
Share This Post
Share on twitter
Share on facebook
Share on linkedin
Share on whatsapp
Share on email